Navigation Links
Many Don't Take Blood Thinner After Getting Stents
Date:4/20/2010

Serious risks double by waiting even a day after discharge, study finds

TUESDAY, April 20 (HealthDay News) -- One of six people who have stents implanted to keep an artery open ignore their doctor's orders to start taking the blood thinner Plavix immediately, and that ignorance nearly doubles their risk for a heart attack or death, new research finds.

The study, which involved 7,402 people who had the thin tubes put in after angioplasty, found that those most likely to benefit from the clot-preventing drug are most likely not to fill the prescription that is a standard part of the hospital discharge routine, said Dr. P. Michael Ho, an associate professor of medicine at the University of Colorado and lead author of a report published online April 20 in Circulation: Cardiovascular Quality and Outcome.

"Older patients are more likely to delay, and patients with previous heart attacks," said Ho, who is also a staff cardiologist at the Denver Veterans Affairs Health Center.

Prescriptions are almost always for clopidogrel (Plavix), the only blood thinner approved for use in the United States in 2004-2007, when the study was done. However, newer clot-preventing drugs are starting to be prescribed more often by U.S. doctors.

The study didn't look for reasons why 16.3 percent of the people who got stents implanted waited at least a day before filling their blood-thinner prescription. The median delay was three days, and 2.2 percent of those who got prescriptions never filled them.

But the study did record the hazards caused by that brief delay -- a 14.2 percent risk for heart attack or death in the next 22 months, compared with a 7.9 percent risk for those who acted promptly.

"Based on previous literature, it could be a lot of confusion about the hospital discharge process," Ho said. "They are given this laundry list of new medications, and they may not absorb all that information at once."

The actual incidence of delayed use of a blood thinner might be greater than that reported in the study, which used data on people enrolled in major integrated health systems, Ho said. "Outside such systems, there are more people with less insurance coverage and higher co-payments, so I suspect the rate might be higher," he noted.

Ho said the study has lessons not only for people who have stents implanted but for their medical caregivers, too.

"For clinicians and hospitals, it is important to look at the discharge process to make sure patients are getting appropriate discharge instructions, and also that they understand the importance of the medications they will be taking," he said. "We as clinicians should highlight the importance of each and every medication."

On the other end, "it is important for patients to ask questions so that they have a good idea of what medications are important to take," Ho said.

Dr. Rob Califf, vice president for clinical research at Duke University, said that it's "critical for doctors and health systems to do everything possible to be sure that people both fill their prescriptions and take their medicine."

One way to do that is to return to a once-common practice of sending someone out of the hospital with a few-day's supply of prescribed medications, said Dr. Stephen A. Siegel, an assistant clinical professor of medicine at New York University. Cost-cutting has eliminated that measure in many hospitals, but it helps ensure that the medication will be taken immediately and that a prescription for it will be filled, Siegel said.

More information

The American Heart Association has more on stents.



SOURCES: P. Michael Ho, M.D., associate professor, medicine, University of Colorado, Denver; Rob Califf, M.D., vice chancellor, clinical research, and professor, medicine, Duke Medicine, Duke University, Durham, N.C.; Stephen A. Siegel, M.D., assistant clinical professor, medicine, New York University, New York City; April 20, 2010, Circulation: Cardiovascular Quality and Outcomes, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. 6 Day Dental and Orthodontics Gets an A+ Check Up
2. Long Island Children's Orthodontist, Dr. Inna Gellerman, Celebrates Season of Giving with Holiday Drives and Events
3. Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York
4. Periodontal pathogens enhance HIV-1 promoter activation in T cells
5. Successful treatment of periodontal disease lowered preterm birth incidences
6. National Prosthodontics Awareness Week Serves and Educates Consumers About Proper Oral Health Care
7. EDS Announces New SafeSiders Endodontic Glide Path Kit
8. Long Island Children's Orthodontist Announces Office Improvements And New Staff Member
9. Blood stem-cell transplant regimen reverses sickle cell disease in adults
10. Blood Thinner Combos Risky for Heart Attack Patients
11. China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 2017 , ... An inventor from Raynham, Mass., knows the ... conjunction with my braces always rubbed against the inside of my cheeks, causing ... problem." The O.B.S. was the result of his brainstorming. , This patent-pending invention ...
(Date:3/29/2017)... ... 29, 2017 , ... The assembly of synthetic DNA has ... repetitive steps and often scientists require many different versions of DNA. Therefore, this ... in a lower error rate and cost saving for reagents and consumables. , ...
(Date:3/29/2017)... North Hollywood, CA (PRWEB) , ... March 29, 2017 , ... ... and Northridge , is now offering laser dental treatments. Dental lasers are safe ... treatments. Laser dentistry expands patients’ options and can improve the overall quality of care. ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... Gastrointestinal Oncology™ (SOGO™), a specialized continuing medical education conference for clinicians who manage ... Intercontinental Time Square, New York. , The program will be led by ...
(Date:3/29/2017)... ... March 29, 2017 , ... AvePoint , the Microsoft Cloud expert, ... in Richmond, Virginia, located at the Riverfront Plaza, 901 East Byrd Street. AvePoint is ... Virginia Ralph S. Northam and Mayor of Richmond Levar M. Stoney. , Founded in ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)...  Glenmark Pharmaceuticals, a global pharmaceutical company, today ... fixed-dose combination of mometasone furoate (25 mcg) and ... nasal spray being studied for the treatment of ... recently completed Phase 3 trial assessing the efficacy ... mometasone, olopatadine or placebo. "We continue ...
(Date:3/29/2017)... 29, 2017 Transparency Market ... provides an exhaustive study of the U.S. substance abuse ... companies are functional in this market at present, ... leading companies, such as GlaxoSmithKline Plc., Pfizer Inc., ... on various marketing strategies to increase their visibility, ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 2.87% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Medicine Technology: